These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2807701)

  • 1. Genetics of variability of CHD risk.
    Sing CF; Moll PP
    Int J Epidemiol; 1989; 18(3 Suppl 1):S183-95. PubMed ID: 2807701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multilocus approach to cardiovascular risk.
    Pallaud C; Maurice M; Cheng S; Grow M; Aguillon D; Sass C; Siest G; Visvikis S
    Scand J Clin Lab Invest Suppl; 1999; 230():168-76. PubMed ID: 10389215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E gene polymorphism and gender.
    Kolovou G; Damaskos D; Anagnostopoulou K; Cokkinos DV
    Ann Clin Lab Sci; 2009; 39(2):120-33. PubMed ID: 19429797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E polymorphism and coronary heart disease.
    Ashavaid TF; Todur SP; Nair KG
    J Assoc Physicians India; 2003 Aug; 51():784-8. PubMed ID: 14651139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe.
    Haddy N; De Bacquer D; Chemaly MM; Maurice M; Ehnholm C; Evans A; Sans S; Do Carmo Martins M; De Backer G; Siest G; Visvikis S
    Eur J Hum Genet; 2002 Dec; 10(12):841-50. PubMed ID: 12461692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals.
    Boerwinkle E; Visvikis S; Welsh D; Steinmetz J; Hanash SM; Sing CF
    Am J Med Genet; 1987 Jul; 27(3):567-82. PubMed ID: 3631131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
    Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
    Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics: polymorphism and risks.
    Ann Biol Clin (Paris); 1985; 43(4):407-17. PubMed ID: 3867299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
    Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The predictive value of apolipoproteins in atheroma].
    Davignon J
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():33-6. PubMed ID: 3113395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of medical genetics on research and practices in the area of cardiovascular disease.
    Berg K
    Clin Genet; 1989 Nov; 36(5):299-312. PubMed ID: 2532083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.